SUBSCRIBE
SUBSCRIBE

Phase 1

Drug Development
4 Biotechs That Could Explode Or Crash In May
May 5, 2017
 · 
1 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Drug Development
3 Cancer Biotechs to Watch at ASCO
May 5, 2017
 · 
2 min read
Secretive Moderna Shakes Up R&D Model, Shows Off Early-Stage Trial Data
Drug Development
Biotech Unicorn Moderna’s Vaccine Performs Well in First Human Trial
April 28, 2017
 · 
2 min read
For Sale: Pfizer's $3.4 Billion Consumer Healthcare Business
Drug Development
The FDA Calls Pfizer’s Next-Generation Lung Cancer Drug a Breakthrough
April 27, 2017
 · 
3 min read
Biotech Bay
Top 15 R&D Spenders In The World For 2017
April 24, 2017
 · 
1 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Drug Development
Why Former Medivation CEO and a Once-Failed Alzheimer’s Drug Could be a Recipe for Disaster for Axovant
April 19, 2017
 · 
3 min read
This Year’s Superbug Norovirus Sickens Hundreds of Millions, Prompting Urgent Race for Vaccine
Drug Development
This Year’s Superbug Norovirus Sickens Hundreds of Millions, Prompting Urgent Race for Vaccine
April 17, 2017
 · 
3 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Drug Development
When It Rains, It Pours: Bay Area’s OncoMed Tanks Again as Lung Cancer Med Fails Phase II, Discontinues Phase I Study
April 17, 2017
 · 
2 min read
Drug Development
Flugen, Inc. Raises $2M More, Provides Update on Phase I Trial
April 12, 2017
 · 
1 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Drug Development
3 Drug Giants That Boasts the Best Pipelines
April 10, 2017
 · 
3 min read
Load More
PRESS RELEASES
Press Releases
Ernexa Therapeutics CEO Corner Highlights Differentiated ERNA-101 Platform as Company Advances Toward Planned First-in-Human Phase 1 Study in 2026
July 14, 2026
 · 
5 min read
Press Releases
Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus
July 14, 2026
 · 
7 min read
Press Releases
Kura Oncology to Present First Long-Term Follow-Up Data Further Supporting Darlifarnib’s Potential to Enhance VEGFR-Targeted Therapy in Renal Cell Carcinoma at KCRS 2026
July 14, 2026
 · 
6 min read
Press Releases
Axiom Biosciences Reports Positive Phase 1 Results for Investigational Stem Cell Therapy in Newborns with Severe Brain Injury
July 14, 2026
 · 
3 min read
Press Releases
Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome
July 14, 2026
 · 
8 min read
Press Releases
Erasca Announces Updated Preliminary Phase 1 Data and Registration-Enabling Plans for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors
July 13, 2026
 · 
9 min read
Press Releases
Zelluna doses first solid tumour patient with ZI-MA4-1 in the ZIMA-101 Phase 1 trial
July 13, 2026
 · 
4 min read
Press Releases
Ollin Biosciences Announces Upcoming Presentations of OLN324 Data in Diabetic Macular Edema and Wet Age-Related Macular Degeneration at the American Society of Retina Specialists (ASRS) 44th Annual Scientific Meeting
July 13, 2026
 · 
2 min read
Press Releases
Ionis doses first participant in Phase 1-2 ASCEND study of ION337 in Dravet syndrome
July 13, 2026
 · 
5 min read
Press Releases
Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes
July 13, 2026
 · 
9 min read
Press Releases
Incyte Presents Phase 1/2 Multidose Data for VGA039 (Latarcibart) at ISTH 2026, Showing Substantial Bleed Reductions in Patients with all Von Willebrand Disease Types
July 13, 2026
 · 
8 min read
Press Releases
New Phase 1 Data Show VNA-318 Mechanism of Action Translates to Humans, Supporting Potential to Address Medical Needs of People with Neurodegenerative Diseases
July 13, 2026
 · 
4 min read
Press Releases
Serina Therapeutics Announces Completion of Sentinel Dosing in Cohort 1 of Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
July 9, 2026
 · 
7 min read
Press Releases
Astellas to Spotlight New Research for Geographic Atrophy at ASRS 2026 Annual Meeting
July 9, 2026
 · 
9 min read
Press Releases
IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx™ DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma
July 9, 2026
 · 
7 min read
Press Releases
Opus Genetics Provides BEST1 Program Update with Detailed Timeline for OPGx-BEST1 Results
July 9, 2026
 · 
7 min read
Press Releases
Blue Earth Therapeutics announces first participant dosed in Phase 1 clinical trial investigating Actinium (²²⁵Ac) rhPSMA-10.1 Injection in metastatic castration-resistant prostate cancer
July 9, 2026
 · 
6 min read
Press Releases
Kenai Therapeutics Announces Completion of Enrollment in Phase 1b/2a REPLACE™ Trial of RNDP-001 in Idiopathic Parkinson’s Disease
July 7, 2026
 · 
4 min read
Press Releases
FibroBiologics Completes Manufacturing of Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
July 7, 2026
 · 
5 min read
Press Releases
Propanc Biopharma Signs MOU with Avance Clinical Pty Ltd
July 7, 2026
 · 
5 min read
Load More